Shares of Jamieson Wellness Inc. (TSE:JWEL - Get Free Report) rose 0.7% on Wednesday . The stock traded as high as C$37.67 and last traded at C$37.40. Approximately 54,907 shares were traded during mid-day trading, a decline of 22% from the average daily volume of 70,737 shares. The stock had previously closed at C$37.15.
Analyst Ratings Changes
JWEL has been the subject of several recent analyst reports. National Bankshares upped their price target on Jamieson Wellness from C$40.00 to C$40.60 and gave the stock an "outperform" rating in a research note on Friday, August 8th. BMO Capital Markets increased their target price on Jamieson Wellness from C$41.00 to C$42.00 and gave the company an "outperform" rating in a research report on Friday, August 8th. TD Securities increased their target price on Jamieson Wellness from C$42.00 to C$45.00 and gave the company a "buy" rating in a research report on Friday, August 8th. Finally, Royal Bank Of Canada increased their target price on Jamieson Wellness from C$40.00 to C$42.00 in a research report on Friday, May 9th. Four research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of C$42.40.
Read Our Latest Research Report on Jamieson Wellness
Jamieson Wellness Stock Up 0.7%
The company has a fifty day moving average of C$35.51 and a two-hundred day moving average of C$33.38. The company has a market cap of C$1.56 billion, a PE ratio of 28.12 and a beta of 1.22. The company has a debt-to-equity ratio of 75.70, a quick ratio of 1.08 and a current ratio of 2.76.
About Jamieson Wellness
(
Get Free Report)
Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Jamieson Wellness, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jamieson Wellness wasn't on the list.
While Jamieson Wellness currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.